FCSR Logo

  • Home
  • Financial Conflict of Interest in Research
  • Research
  • Homepage

Enhancement of NKG2DL-induced anti-tumor response in Hodgkin lymphoma: ERp5 and ADAMs as Therapeutic targets

Published January 24, 2013 at 295 × 198 in Enhancement of NKG2DL-induced anti-tumor response in Hodgkin lymphoma: ERp5 and ADAMs as Therapeutic targets.
← Previous Next →
Mappa del sito | Area Stampa | Benefici fiscali | Webmaster | FCSR Cookie Policy | Privacy Policy

Copyright Reserved ©. 2025